Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

The first clinical guidelines on the use of blood biomarker tests could help clinicians choose the most appropriate test to ...

In the early stages of Alzheimer’s disease, people may have trouble following conversations, repeat themselves, or struggle ...

Biogen Inc. (NASDAQ:BIIB) reported on Thursday that the second quarter of 2025 adjusted earnings per share were $5.47, up 4% ...

A new study shows that the way amyloid proteins—implicated in Alzheimer's disease—assemble into fibrils can be significantly ...

A hit Bollywood film sparks public curiosity about early-onset Alzheimer’s — experts break down its causes, symptoms, and how ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope. “Alzheimer’s disease is a specific condition resulting from an abnormal biological ...

The combination of a recently approved blood test for detection of Alzheimer’s disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...

Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...